Last quarter (Q ), Pathfinder Cell Therapy's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Pathfinder Cell Therapy's net income was $-289.00K. See Pathfinder Cell Therapy’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 14	Dec 13	Dec 12	Dec 11	Dec 10
Total Revenue	-	$ 0.00	$ 54.00K	$ 114.00K	$ 73.00K	$ 0.00
Cost of Revenue	-	$ 0.00	$ 37.00K	$ 50.00K	$ 26.00K	$ 0.00
Gross Profit	-	$ 0.00	$ 17.00K	$ 64.00K	$ 47.00K	$ 0.00
Operating Expense	$ 775.00K	$ 1.12M	$ 1.62M	$ 2.12M	$ 3.67M	$ 827.00K
Operating Income	$ -775.00K	$ -1.12M	$ -1.60M	$ -2.06M	$ -3.62M	$ -827.00K
Net Non Operating Interest Income Expense	$ -305.00K	$ -275.00K	$ -195.00K	$ -96.00K	$ -108.00K	$ -8.00K
Other Income Expense	-	-	$ 89.00K	-	$ -7.54M	$ -459.00K
Pretax Income	$ -1.08M	$ -1.39M	$ -1.71M	$ -2.16M	$ -11.27M	$ -1.29M
Tax Provision	-	-	-	-	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -1.08M	$ -1.39M	$ -1.71M	$ -2.16M	$ -11.27M	$ -1.29M
Basic EPS	$ <0.01	$ 0.00	$ 0.00	$ >-0.01	$ -0.02	$ -0.02
Diluted EPS	$ >-0.01	$ 0.00	$ 0.00	$ >-0.01	$ -0.02	$ -0.02
Basic Average Shares	$ 2.67B	$ 667.16M	$ 667.16M	$ 667.16M	$ 526.11M	$ 109.44M
Diluted Average Shares	$ 2.67B	$ 667.16M	$ 667.16M	$ 667.16M	$ 526.11M	$ 109.44M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 775.00K	$ 1.12M	$ 1.65M	$ 2.17M	$ 3.69M	$ 827.00K
Net Income From Continuing And Discontinued Operation	$ -1.08M	$ -1.39M	$ -1.71M	$ -2.16M	$ -11.27M	$ -1.29M
Normalized Income	$ -1.08M	$ -1.39M	$ -1.79M	$ -2.16M	$ -3.73M	$ -835.00K
Interest Expense	$ 230.00K	-	-	-	-	$ 12.00K
EBIT	$ -775.00K	$ -1.12M	$ -1.60M	$ -2.06M	$ -3.62M	$ -827.00K
EBITDA	$ -772.00K	$ -1.12M	$ -1.59M	$ -2.04M	$ -3.60M	$ -815.00K

Currency in USD

Pathfinder Cell Therapy Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing